The increasing problem of “Bizarro K2 Liquid,” a novel synthetic cannabinoid, is raising substantial worry for medical officials and authorities. Incidences of negative reactions linked to this specific liquid are expanding rapidly, demonstrating a possible public health crisis. Specialists think the simple availability and incorrect marketing